Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03974334 · ClinicalTrials.gov registry record · NA

Reducing Disparities in the Treatment of Hypertension Using the OWL mHealth Tool

A NA study of Hypertension, sponsored by Paula Gardiner.

Completed
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT03974334: Completed NA study of Hypertension, sponsored by Paula Gardiner.

NCT03974334 is a NA study of Hypertension that has completed, run by Paula Gardiner. The registered enrollment target is 25 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03974334, a NA study of Hypertension, has completed, sponsored by Paula Gardiner.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

This is a one-year study. The study's primary outcome is successful improvement of the Our Whole Lives for Hypertension (OWL-H) online patient education platform, based upon participant use and focus group feedback, to deliver information on self-management of hypertension and other cardiac risk factors, and to encourage self-monitoring of blood pressure. Specific Aim 1 - To pilot test the OWL-H platform for 8 weeks with 26 patients with hypertension (2 groups of 13) to refine its utility for home self-monitoring (number of times patients record home blood pressure and input this data onto OWL-H and engagement of self-management (i.e. # of logins, # of mind body sessions completed, # of times modules accessed each day)). Hypothesis 1: Eighty percent of patients will log in and record their blood pressures. Specific Aim 2 - At the end of each group, hold a focus group to obtain information about: 1) the barriers and facilitators of using the OWL-H platform and using OWL-H to self-monitor blood pressure at home, 2) satisfaction with OWL-H, 3) how OWL-H helped with reduction of number of cardiac risk factors (e.g., smoking, eating habits, perceived stress, and amount of exercise and health-related quality of life).

Primary Outcome

The Blood Pressure Knowledge Questionnaire (BPKQ) was used to assess the participants' level of knowledge regarding common characteristics and risk factors of hypertension. It consists of 8 items covering topics like common symptoms, White Coat Syndrome, and the amount of salt consumed by the average American, with a mix of multiple choice (6 items) and true/false questions (2 items). The correct items are totaled, with a range of 1-8, and higher scores indicating more hypertension knowledge. Th

Conditions Studied

Interventions

  • BEHAVIORAL OWL-Hypertension 8 Wk Trial

Study Locations (1)

Massachusetts

  • University of Massachusetts Medical School - Worcester

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2019-07-16
Est. Completion 2019-12-18
Phase NA
Paula Gardiner

1 total trials

What the finished NCT03974334 record still lists

NCT03974334 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which OWL-Hypertension 8 Wk Trial is the first listed.

NCT03974334 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03974334 about?

NCT03974334 is a clinical study titled "Reducing Disparities in the Treatment of Hypertension Using the OWL mHealth Tool". This is a one-year study. The study's primary outcome is successful improvement of the Our Whole Lives for Hypertension (OWL-H) online patient education platform, based upon participant use and focus group feedback, to deliver information on self-management of hypertension and other cardiac risk fac...

What is the current status of trial NCT03974334?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-07-16. Estimated completion is 2019-12-18.

What conditions does trial NCT03974334 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT03974334?

The interventions under investigation include: OWL-Hypertension 8 Wk Trial (BEHAVIORAL).

Who is sponsoring clinical trial NCT03974334?

This trial is sponsored by Paula Gardiner, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03974334 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03974334's enrollment target sits among peer trials

25 423rd of 470 higher than 43 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03974334, the US trial registry maintained by the National Library of Medicine. NCT03974334 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.